Cover Image for The Future of Techbio with Becky Pferdehirt, Partner at a16z

The Future of Techbio with Becky Pferdehirt, Partner at a16z

 
 
Register to See Address
San Francisco, United States
Registration
Past Event
Welcome! To join the event, please register below.
About Event

We're excited to host Becky Pferdehirt for a fireside chat on the future of techbio and how it differs from biotech. Becky is a partner on the bio investing team at a16z. She focuses on early stage companies building technology platforms for therapeutic discovery and development.

Prior to joining Andreessen Horowitz, Becky worked at Amgen where she most recently led business development efforts for therapeutic platform partnerships. Before moving to BD Becky was a research scientist in Amgen R&D, focused on cell and gene therapy technology innovation.

Becky completed her postdoctoral education at Genentech studying cancer cell biology and proteomics. She holds a PhD in Molecular and Cellular Biology from UC Berkeley and a BS in Biology from MIT.